Lasix (Furosemide Sodium)

Furosemide blocks the Na+/K+/2Cl‑ transporter in the thick ascending limb of the loop of Henle. This inhibition stops reabsorption of sodium, potassium, and chloride, creating an osmotic gradient that pulls water into the urine. The result is increased diuresis and a reduction in fluid volume.

The appropriate dose of Lasix is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and renal function. Dosage may vary widely, and the prescriber will tailor the regimen to achieve the desired diuretic effect while minimizing adverse reactions.

Safety data for furosemide in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the Lasix product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Lasix is a loop diuretic, which is more potent than thiazide diuretics for removing large volumes of fluid. It acts on the loop of Henle, whereas thiazides act on the distal convoluted tubule. Loop diuretics are preferred for acute pulmonary edema and severe renal or hepatic fluid overload, while thiazides are often used for mild hypertension.

Lasix should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product in a dry place and avoid exposure to extreme temperatures. Do not refrigerate unless specifically instructed by the manufacturer.

Lasix is supplied as an injectable solution for intramuscular (IM) or intravenous (IV) administration. The healthcare professional selects the route based on clinical need, typically delivering the dose slowly by IV infusion or as a rapid IM injection, following aseptic technique and appropriate dosing guidelines.

Serious risks include ototoxicity, which can cause hearing loss, severe electrolyte disturbances such as hypokalemia or hyponatremia, marked hypotension, and acute kidney injury. Patients should be monitored closely for signs of these complications, especially when high doses or prolonged therapy are used.

Lasix is contraindicated in patients with anuria (no urine output), severe electrolyte depletion, or known hypersensitivity to furosemide or sulfonamide derivatives. Caution is also advised for individuals with severe hepatic impairment, uncontrolled diabetes, or those taking medications that may interact adversely.